Confo Therapeutics
Dr Tim Corn became Medical Advisor to Confo Therapeutics in 2017.
Dr. Corn is an independent pharmaceuticals consultant, who serves on several company Boards and advises biopharmaceutical companies on clinical development and regulatory affairs. He was formerly Chief Medical Officer International at Jazz Pharmaceuticals, and CMO at EUSA Pharma and Zeneus Pharma, having held senior positions in both big and small pharma and in the UK regulatory agency.
Dr. Corn qualified in medicine at London University and became honorary Consultant and Senior Lecturer at the Institute of Psychiatry, London before joining the pharma sector.
This person is not in the org chart
This person is not in any offices
Confo Therapeutics
1 followers
Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for GPCR drug discovery.